[go: up one dir, main page]

BR0116554A - Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão - Google Patents

Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão

Info

Publication number
BR0116554A
BR0116554A BR0116554-2A BR0116554A BR0116554A BR 0116554 A BR0116554 A BR 0116554A BR 0116554 A BR0116554 A BR 0116554A BR 0116554 A BR0116554 A BR 0116554A
Authority
BR
Brazil
Prior art keywords
hypertension
treatment
angina
prevention
pharmaceutical composition
Prior art date
Application number
BR0116554-2A
Other languages
English (en)
Inventor
Jacobus Maria Lemmens
Theodorus Hendricus Ant Peters
Franciscus Bernardus Benneker
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29740324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0116554(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of BR0116554A publication Critical patent/BR0116554A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA PARA O TRATAMENTO DA ANGINA OU HIPERTENSãO, PROCESSO, PROCESSO PARA O TRATAMENTO OU PREVENçãO DA ANGINA OU HIPERTENSãO, COMPOSIçãO DO INGREDIENTE FARMACêUTICAMENTE ATIVO E COMPOSIçãO FARMACêUTICA PARA O TRATAMENTO OU PREVENçãO DA ANGINA OU HIPERTENSãO". Um derivado de amlodipina possuindo a fórmula seguinte é útil como uma substância farmacêutica, seja sozinho ou em combinação com amlodipina, no tratamento da angina e da hipertensão.
BR0116554-2A 2000-12-29 2001-08-15 Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão BR0116554A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25858500P 2000-12-29 2000-12-29
US80934801A 2001-03-16 2001-03-16
PCT/NL2001/000604 WO2002053541A1 (en) 2000-12-29 2001-08-15 Amide derivative of amlodipine
BE2001/0708A BE1014451A6 (nl) 2000-12-29 2001-11-05 Amidederivaat van amlodipine.

Publications (1)

Publication Number Publication Date
BR0116554A true BR0116554A (pt) 2004-02-03

Family

ID=29740324

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0116554-2A BR0116554A (pt) 2000-12-29 2001-08-15 Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão

Country Status (7)

Country Link
US (2) US6602893B2 (pt)
EP (1) EP1309554A1 (pt)
BE (1) BE1014451A6 (pt)
BR (1) BR0116554A (pt)
CA (1) CA2433193C (pt)
DE (1) DE20115218U1 (pt)
WO (1) WO2002053541A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
SI1309555T1 (sl) * 2000-12-29 2005-12-31 Pfizer Ltd Postopek izdelave amlodipin-maleata
MXPA03005882A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
EP1309554A1 (en) * 2000-12-29 2003-05-14 Synthon Licensing, Ltd. Amide derivative of amlodipine
EP1499592A4 (en) * 2002-04-13 2010-01-13 Hanlim Pharmaceutical Co Ltd AMLODIPINNICOTINATE AND METHOD FOR THE PRODUCTION THEREOF
US7230017B2 (en) 2002-08-27 2007-06-12 Bayer Healthcare Ag Dihydropyridinone derivatives
US10695329B2 (en) 2016-10-07 2020-06-30 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
CA3096101A1 (en) 2018-04-11 2019-10-17 Silvergate Pharmaceuticals, Inc. Amlodipine formulations

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
PT77842B (en) * 1982-12-21 1986-05-05 Pfizer Process for preparing dihydropyridines
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US4983740A (en) 1986-08-04 1991-01-08 Adir Et Compagnie Process for 1,4-dihydropyridine compounds
GB8710493D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
WO1993006082A1 (en) 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
US5389654A (en) 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
HU221810B1 (hu) 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
PL189666B1 (pl) 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
ES2151850B1 (es) 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
GB9827431D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel compound
GB9827387D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel process
EP1309556B1 (en) * 2000-12-29 2004-11-24 Pfizer Limited Amlodipine fumarate
SI1309555T1 (sl) * 2000-12-29 2005-12-31 Pfizer Ltd Postopek izdelave amlodipin-maleata
EP1309557B9 (en) * 2000-12-29 2006-11-15 Pfizer Limited Amlodipine hemimaleate
MXPA03005886A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado de aspartato de amlodipina como antagonista del canal de calcio.
EP1309554A1 (en) * 2000-12-29 2003-05-14 Synthon Licensing, Ltd. Amide derivative of amlodipine
EP1346214A2 (en) 2000-12-29 2003-09-24 Pfizer Limited Reference standards and processes for determining the purity or stability of amlodipine maleate
GB0114709D0 (en) 2001-06-15 2001-08-08 Pfizer Ltd Stabilised formulations of amlodipine maleate

Also Published As

Publication number Publication date
EP1309554A1 (en) 2003-05-14
BE1014451A6 (nl) 2003-10-07
US6602893B2 (en) 2003-08-05
US20020123518A1 (en) 2002-09-05
CA2433193A1 (en) 2002-07-11
CA2433193C (en) 2006-01-31
US20030204093A1 (en) 2003-10-30
US7115638B2 (en) 2006-10-03
WO2002053541A1 (en) 2002-07-11
DE20115218U1 (de) 2002-01-24

Similar Documents

Publication Publication Date Title
DE69713148D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
BR0112292A (pt) Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
BRPI0313286A2 (pt) Composição e atividade antiviral de derivados de piperazina azaindoloxoacético substituìda
DE69713152D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
IS8502A (is) Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar
ATE266636T1 (de) Benzimidazolinone, benzoxazolinone, benzopiperazinone, indanone und deren derivate als faktor xa inhibitoren
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
BR0213452A (pt) Derivados de piperazina com atividade antagonista receptora de ccr1
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
BR0100558A (pt) Composições e métodos para tratar a osteoporose
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
SE9903759D0 (sv) Pharmaceutically active compounds
NO20022442L (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
BR0315777A (pt) Uso de derivados de piperazina como antagonistas ccr1
NO954878L (no) Pyrrolderivater
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
SE9802208D0 (sv) Novel compounds
BR0116554A (pt) Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão
BR0116553A (pt) Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão
EP2138175A3 (en) Formulations comprising valsartan for treating diabetes or microalbuminuria
SE9902267D0 (sv) New compounds
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
BR0012327A (pt) Pirrolidinas e piperidinas neurotróficas, e composições e métodos relacionados

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A, 9A E 10A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.